Noticias

Switching from a ritonavir-boosted protease inhibitor to a dolutegravir-based regimen for maintenance ofHIV viral suppression in patients with high cardiovascular

1 Febrero, 2018

Dr. Esteban Martínez. Infectious Diseases Unit. Hospital Clínic, University of Barcelona

Accesos directos